Related Experiment Video

Updated: Jun 23, 2026

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

[Percutaneous aortic valve replacement in high risk patients]

T Chatterjee1, C A Nienaber, H Schneider

  • 1Abteilung für Kardiologie, Universitätsklinikum Rostock, Rostock.

Praxis
|May 1, 2009
PubMed

Insights

Degenerative aortic stenosis, a common heart valve disease, affects many adults. Percutaneous aortic valve replacement offers a new durable treatment option for patients unsuitable for traditional surgery.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Interventional Cardiology

Background:

  • Degenerative, calcified aortic stenosis is the most prevalent form of adult valvular heart disease.
  • Surgical aortic valve replacement is the standard treatment for eligible patients.
  • Many patients are excluded from surgery due to advanced age and comorbidities, leading to unmet treatment needs.

Purpose of the Study:

  • To highlight the challenges in treating aortic stenosis in elderly and comorbid patients.
  • To introduce percutaneous aortic valve replacement as a novel therapeutic option.

Main Methods:

  • Review of current treatment guidelines for aortic stenosis.
  • Discussion of the evolution of treatment strategies.
  • Focus on the advent and implications of percutaneous aortic valve replacement.

Main Results:

  • Surgical aortic valve replacement is effective but not feasible for all patients.
  • Percutaneous aortic valve replacement provides a viable alternative for high-risk surgical candidates.
  • This minimally invasive approach expands treatment accessibility.

Conclusions:

  • Percutaneous aortic valve replacement represents a significant advancement in managing aortic stenosis.
  • It offers a durable and effective treatment for patients previously denied surgical intervention.
  • The development signifies a new era in valvular heart disease therapy.

More Related Videos

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...